These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 24973908

  • 1. Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
    Cabellos C, Garrigós C, Taberner F, Force E, Pachón-Ibañez ME.
    J Infect Chemother; 2014 Sep; 20(9):563-8. PubMed ID: 24973908
    [Abstract] [Full Text] [Related]

  • 2. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A, Ribes S, Cabellos C, Taberner F, Tubau F, Domínguez MA, Montero A, Liñares J, Ariza J, Gudiol F.
    J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Ribes S, Pachón-Ibáñez ME, Domínguez MA, Fernández R, Tubau F, Ariza J, Gudiol F, Cabellos C.
    Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1361-7. PubMed ID: 20680368
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T, Skiadas I, Koutoukas P, Adamis T, Baxevanos N, Tzepi I, Pelekanou A, Giamarellos-Bourboulis EJ, Giamarellou H, Kanellakopoulou K.
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.
    Bal AM, Gould IM.
    Expert Opin Pharmacother; 2005 Oct; 6(13):2257-69. PubMed ID: 16218886
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C, Caillon J, Le Mabecque V, Miegeville AF, Donnio PY, Bugnon D, Potel G.
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [Abstract] [Full Text] [Related]

  • 7. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model.
    Calik S, Turhan T, Yurtseven T, Sipahi OR, Buke C.
    Med Sci Monit; 2012 Nov; 18(11):SC5-8. PubMed ID: 23111752
    [Abstract] [Full Text] [Related]

  • 8. Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of Staphylococcus aureus infections: an in vitro and in vivo evaluation against strains with reduced susceptibility to glycopeptides.
    Betts JW, Abdul Momin HF, Phee LM, Wareham DW.
    J Med Microbiol; 2018 Feb; 67(2):265-271. PubMed ID: 29300156
    [Abstract] [Full Text] [Related]

  • 9. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M, Sacar S, Kaleli I, Onem G, Turgut H, Goksin I, Ozcan V, Kaan Inan B, Duver H, Baltalarli A.
    J Surg Res; 2007 May 15; 139(2):170-5. PubMed ID: 17292421
    [Abstract] [Full Text] [Related]

  • 10. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, Ge JY, Potel G.
    Antimicrob Agents Chemother; 2007 Sep 15; 51(9):3397-400. PubMed ID: 17591849
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.
    Jacqueline C, Navas D, Batard E, Miegeville AF, Le Mabecque V, Kergueris MF, Bugnon D, Potel G, Caillon J.
    Antimicrob Agents Chemother; 2005 Jan 15; 49(1):45-51. PubMed ID: 15616274
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM, Colombo Gainza E, Gil Brusola A, Ortiz Estévez R, Cantón E, Gobernado M.
    Rev Esp Quimioter; 2006 Sep 15; 19(3):252-7. PubMed ID: 17099793
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA).
    Leonard SN, Szeto YG, Zolotarev M, Grigoryan IV.
    Int J Antimicrob Agents; 2011 Jun 15; 37(6):558-61. PubMed ID: 21497067
    [Abstract] [Full Text] [Related]

  • 14. A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections.
    Domenech A, Ribes S, Cabellos C, Domínguez MA, Montero A, Liñares J, Ariza J, Gudiol F.
    Microb Drug Resist; 2004 Jun 15; 10(4):346-53. PubMed ID: 15650381
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Park HJ, Kim SH, Kim MJ, Lee YM, Park SY, Moon SM, Park KH, Chong YP, Lee SO, Choi SH, Woo JH, Kim YS.
    J Infect; 2012 Dec 15; 65(6):505-12. PubMed ID: 22902942
    [Abstract] [Full Text] [Related]

  • 16. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C, Parra-Ruiz J, Winterfield P, Rybak MJ.
    Int J Antimicrob Agents; 2011 Oct 15; 38(4):301-6. PubMed ID: 21764263
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model.
    Conaughty JM, Chen J, Martinez OV, Chiappetta G, Brookfield KF, Eismont FJ.
    Spine (Phila Pa 1976); 2006 Oct 15; 31(22):E830-2. PubMed ID: 17047530
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
    Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Silvestri C, Licci A, De Fusco M, Provinciali M, Saba V, Scalise G.
    Antimicrob Agents Chemother; 2005 Oct 15; 49(10):4042-5. PubMed ID: 16189078
    [Abstract] [Full Text] [Related]

  • 19. Minimal inhibitory concentration drift of glycopeptides and linezolid against S. Aureus at a Chinese children's center, 2009-2013.
    Jing CM, Xie W, Chen Y, Wang C.
    Pediatr Infect Dis J; 2015 Jan 15; 34(1):108-11. PubMed ID: 25741804
    [Abstract] [Full Text] [Related]

  • 20. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M, Yazgi H, Aktaş E, Ayyildiz A, Parlak M.
    Mikrobiyol Bul; 2003 Oct 15; 37(4):235-40. PubMed ID: 14748259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.